Codex Capital’s Merck MRK Stock Holding History

Codex Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$7.13M	Buy	54,000 +14,750	+38%	+$1.82M	3.47%	10
2023 Q4	$4.28M	Buy	39,250 +1,000	+3%	+$104K	2.5%	19
2023 Q3	$3.94M	Hold	38,250	–	–	2.54%	19
2023 Q2	$4.35M	Buy	+38,250	New	+$4.34M	2.8%	16

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Codex Capital's MRK Position: Q1 2024 in Review

Codex Capital increased its Merck (MRK) stake by 38% in Q1 2024, buying an estimated $1.82M and bringing the position to 54,000 shares worth $7.13M. The position accounts for 3.47% of the portfolio, ranked #10.

Codex Capital first reported a position in MRK in Q2 2023 and has held it in 4 quarters since. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

Codex Capital held 54,000 shares of Merck worth $7.13M as of Q1 2024.
Codex Capital bought 14,750 Merck shares in Q1 2024, an estimated $1.82M.
Merck made up 3.47% of Codex Capital's portfolio in Q1 2024, its #10 holding.
Codex Capital first reported a position in Merck in Q2 2023 and has held it in 4 quarters since.
3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Codex Capital's 13F filing for Q1 2024, filed 7 May 2024.